- Advertisement -

Atomic ‘patchwork’ using heteroepitaxy for next generation semiconductor devices

Continuous process for engineering 2D transition metal dichalcogenide (TMDC) heterostructures Credit: Tokyo Metropolitan University Tokyo, Japan – Researchers...

Study questions whether pubs can effectively prevent COVID-19 transmission risk

Credit: University of Stirling A new first-of-its-kind study has questioned whether pub operators can effectively and consistently...

Beckman Coulter Life Sciences launches Biomek NGeniuS Next Generation Library Prep System

Beckman Coulter Life Sciences, a global leader in laboratory workflow automation and innovation, and a company of Danaher Corporation, unleashes the power of next...

A recombinant platform for flavivirus vaccines and diagnostics using chimeras

A new technology to produce safer ‘hybrid’ viruses at high volumes for use in vaccines and diagnostics for mosquito-borne diseases has been developed at...

Artisanal Fishers Match Satellite Accuracy in Environmental Data Collection

Artisanal fishers in the eastern Aegean Sea have been recognized for their invaluable local ecological knowledge (LEK) in a groundbreaking study that underscores the...

Base Editor Converts “Wanted” Cs, Spares “Bystander” Cs

“Round up the usual suspects!” This expression, which bespeaks expediency, could apply to the gene editing tools known as cytosine base editors (CBEs). CBEs,...

Aprea Expands Development of WEE1 Inhibitor After Seeing Early Clinical Activity...

Aprea Therapeutics is accelerating enrollment in its ongoing Phase I trial of its targeted cancer therapy APR-1051, one of the precision oncology drug developer’s...

Myotis Bat Genomes Reveal How They Fight Viruses, Cancer, and Cellular...

Bats are among the most diverse mammalian species—second only to rodents—and are anomalies in the mammalian world: they fly, have long lifespans for their...

Aprea Expands Development of WEE1 Inhibitor After Seeing Early Clinical Activity Signs vs. Cancer

Aprea Therapeutics is accelerating enrollment in its ongoing Phase I trial of its targeted cancer therapy APR-1051, one of the precision oncology drug developer’s...

Myotis Bat Genomes Reveal How They Fight Viruses, Cancer, and Cellular Damage

Bats are among the most diverse mammalian species—second only to rodents—and are anomalies in the mammalian world: they fly, have long lifespans for their...

Expanded Synthetic Promoter Library Introduced to Boost Biomanufacturing Operations

SynGenSys, based in Sheffield, U.K., reports that it has introduced its CHO.SET® 2.0 synthetic gene promoter system to improve protein production in CHO (Chinese...

more new items

Aprea Expands Development of WEE1 Inhibitor After Seeing Early Clinical Activity...

Aprea Therapeutics is accelerating enrollment in its ongoing Phase I trial of its targeted cancer therapy APR-1051, one of the precision oncology drug developer’s...

Myotis Bat Genomes Reveal How They Fight Viruses, Cancer, and Cellular...

Bats are among the most diverse mammalian species—second only to rodents—and are anomalies in the mammalian world: they fly, have long lifespans for their...

Expanded Synthetic Promoter Library Introduced to Boost Biomanufacturing Operations

SynGenSys, based in Sheffield, U.K., reports that it has introduced its CHO.SET® 2.0 synthetic gene promoter system to improve protein production in CHO (Chinese...